{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:02:28Z","timestamp":1774512148110,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00115-025-01804-y","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T13:05:20Z","timestamp":1740056720000},"page":"230-237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmakotherapie der Essst\u00f6rungen\u00a0\u2013 ein Update","Pharmacotherapy of eating disorders\u2014An update"],"prefix":"10.1007","volume":"96","author":[{"given":"Tabea","family":"Bauman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Voderholzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"1804_CR1","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00787-021-01778-7","volume":"31","author":"J Antel","year":"2022","unstructured":"Antel\u00a0J, Tan\u00a0S, Grabler\u00a0M, Ludwig\u00a0C, Lohkemper\u00a0D, Brandenburg\u00a0T, Barth\u00a0N, Hinney\u00a0A, Libuda\u00a0L, Remy\u00a0M, Milos\u00a0G, Hebebrand\u00a0J (2022) Rapid amelioration of anorexia nervosa in a\u00a0male adolescent during metreleptin treatment including recovery from hypogonadotropic hypogonadism. Eur Child Adolesc Psychiatry 31:1573\u20131579","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1804_CR2","first-page":"100333","volume":"35","author":"L Aoun","year":"2024","unstructured":"Aoun\u00a0L, Almardini\u00a0S, Saliba\u00a0F, Haddadin\u00a0F, Mourad\u00a0O, Jdaidani\u00a0J, Morcos\u00a0Z, Al Saidi\u00a0I, Bou Sanayeh\u00a0E, Saliba\u00a0S, Almardini\u00a0M, Zaidan\u00a0J (2024) GLP\u20111 receptor agonists: A\u00a0novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A\u00a0systematic review. J\u00a0Clin Transl Endocrinol 35:100333","journal-title":"J Clin Transl Endocrinol"},{"key":"1804_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.4088\/JCP.v63n1113","volume":"63","author":"LM Arnold","year":"2002","unstructured":"Arnold\u00a0LM, McElroy\u00a0SL, Hudson\u00a0JI, Welge\u00a0JA, Bennett\u00a0AJ, Keck\u00a0PE (2002) A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J\u00a0Clin Psychiatry 63:1028\u20131033","journal-title":"J Clin Psychiatry"},{"key":"1804_CR4","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1017\/S0033291711000390","volume":"41","author":"E Attia","year":"2011","unstructured":"Attia\u00a0E, Kaplan\u00a0AS, Walsh\u00a0BT, Gershkovich\u00a0M, Yilmaz\u00a0Z, Musante\u00a0D, Wang\u00a0Y (2011) Olanzapine versus placebo for out-patients with anorexia nervosa. Psychol Med 41:2177\u20132182","journal-title":"Psychol Med"},{"key":"1804_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1176\/appi.ajp.2018.18101125","volume":"176","author":"E Attia","year":"2019","unstructured":"Attia\u00a0E, Steinglass\u00a0JE, Walsh\u00a0BT, Wang\u00a0Y, Wu\u00a0P, Schreyer\u00a0C, Wildes\u00a0J, Yilmaz\u00a0Z, Guarda\u00a0AS, Kaplan\u00a0AS, Marcus\u00a0MD (2019) Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A\u00a0Randomized Clinical Trial. Am J Psychiatry 176:449\u2013456","journal-title":"Am J Psychiatry"},{"key":"1804_CR6","doi-asserted-by":"publisher","DOI":"10.1055\/a-2436-9552","author":"T Bauman","year":"2024","unstructured":"Bauman\u00a0T, Kolar\u00a0DR, Correll\u00a0CU, Haas\u00a0V, Voderholzer\u00a0U (2024) Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa. Pharmacopsychiatry. https:\/\/doi.org\/10.1055\/a-2436-9552","journal-title":"Pharmacopsychiatry"},{"key":"1804_CR7","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1176\/appi.ajp.2008.07121900","volume":"165","author":"H Bissada","year":"2008","unstructured":"Bissada\u00a0H, Tasca\u00a0GA, Barber\u00a0AM, Bradwejn\u00a0J (2008) Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a\u00a0randomized, double-blind, placebo-controlled trial. Am J Psychiatry 165:1281\u20131288","journal-title":"Am J Psychiatry"},{"key":"1804_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/YIC.0b013e328080ca31","volume":"22","author":"F Brambilla","year":"2007","unstructured":"Brambilla\u00a0F, Garcia\u00a0CS, Fassino\u00a0S, Daga\u00a0GA, Favaro\u00a0A, Santonastaso\u00a0P, Ramaciotti\u00a0C, Bondi\u00a0E, Mellado\u00a0C, Borriello\u00a0R, Monteleone\u00a0P (2007) Olanzapine therapy in anorexia nervosa: psychobiological effects. Int Clin Psychopharmacol 22:197\u2013204","journal-title":"Int Clin Psychopharmacol"},{"key":"1804_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1176\/appi.ajp.23180001","volume":"180","author":"C Crone","year":"2023","unstructured":"Crone\u00a0C, Fochtmann\u00a0LJ, Attia\u00a0E, Boland\u00a0R, Escobar\u00a0J, Fornari\u00a0V, Golden\u00a0N, Guarda\u00a0A, Jackson-Triche\u00a0M, Manzo\u00a0L, Mascolo\u00a0M, Pierce\u00a0K, Riddle\u00a0M, Seritan\u00a0A, Uniacke\u00a0B, Zucker\u00a0N, Yager\u00a0J, Craig\u00a0TJ, Hong\u00a0SH, Medicus\u00a0J (2023) The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders. Am J Psychiatry 180:167\u2013171","journal-title":"Am J Psychiatry"},{"key":"1804_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.26502\/fjwhd.2644-28840044","volume":"3","author":"E Dechant","year":"2020","unstructured":"Dechant\u00a0E, Boyle\u00a0B, Ross\u00a0R (2020) Ketamine in a\u00a0Patient with Comorbid Anorexia and MDD. J\u00a0Women\u2019s Health Dev 3:373\u2013375","journal-title":"J Women\u2019s Health Dev"},{"key":"1804_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/oby.2005.126","volume":"13","author":"MJ Devlin","year":"2005","unstructured":"Devlin\u00a0MJ, Goldfein\u00a0JA, Petkova\u00a0E, Jiang\u00a0H, Raizman\u00a0PS, Wolk\u00a0S, Mayer\u00a0L, Carino\u00a0J, Bellace\u00a0D, Kamenetz\u00a0C, Dobrow\u00a0I, Walsh\u00a0BT (2005) Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. Obes Res 13:1077\u20131088","journal-title":"Obes Res"},{"key":"1804_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40337-014-0027-x","volume":"2","author":"J de Vos","year":"2014","unstructured":"de Vos\u00a0J, Houtzager\u00a0L, Katsaragaki\u00a0G, van de Berg\u00a0E, Cuijpers\u00a0P, Dekker\u00a0J (2014) Meta analysis on the efficacy of pharmacotherapy versus placebo on anorexia nervosa. J\u00a0Eat Disord 2:27","journal-title":"J Eat Disord"},{"key":"1804_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000369978","volume":"84","author":"M Dold","year":"2015","unstructured":"Dold\u00a0M, Aigner\u00a0M, Klabunde\u00a0M, Treasure\u00a0J, Kasper\u00a0S (2015) Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A\u00a0Meta-Analysis of Randomized Controlled Trials. Psychother Psychosom 84:110\u2013116","journal-title":"Psychother Psychosom"},{"key":"1804_CR14","doi-asserted-by":"crossref","unstructured":"Fazeli PK, Lawson EA, Faje AT, Eddy KT, Lee H, Fiedorek FT, Breggia A, Gaal IM, DeSanti R, Klibanski A (2018) Treatment With a\u00a0Ghrelin Agonist in Outpatient Women With Anorexia Nervosa: A\u00a0Randomized Clinical Trial. Journal of Clinical Psychiatry 79:17m11585","DOI":"10.4088\/JCP.17m11585"},{"key":"1804_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/(SICI)1098-108X(199901)25:1<11::AID-EAT2>3.0.CO;2-U","volume":"25","author":"CP Ferguson","year":"1999","unstructured":"Ferguson\u00a0CP, La Via\u00a0MC, Crossan\u00a0PJ, Kaye\u00a0WH (1999) Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa? Int J Eat Disord 25:11\u201317","journal-title":"Int J Eat Disord"},{"key":"1804_CR16","doi-asserted-by":"crossref","unstructured":"Fluoxetine Bulimia Nervosa Collaborative Study Group (1992) Fluoxetine in the treatment of bulimia nervosa. A\u00a0multicenter, placebo-controlled, double-blind trial. Archives Of General Psychiatry 49:139\u2013147","DOI":"10.1001\/archpsyc.1992.01820020059008"},{"key":"1804_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1192\/bjp.166.5.660","volume":"166","author":"DJ Goldstein","year":"1995","unstructured":"Goldstein\u00a0DJ, Wilson\u00a0MG, Thompson\u00a0VL, Potvin\u00a0JH, Rampey\u00a0AH Jr (1995) Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. Br J Psychiatry 166:660\u2013666","journal-title":"Br J Psychiatry"},{"key":"1804_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000527386","volume":"16","author":"G Gradl-Dietsch","year":"2023","unstructured":"Gradl-Dietsch\u00a0G, Milos\u00a0G, Wabitsch\u00a0M, Bell\u00a0R, Tsch\u00f6pe\u00a0F, Antel\u00a0J, Hebebrand\u00a0J (2023) Rapid Emergence of Appetite and Hunger Resulting in Weight Gain and Improvement of Eating Disorder Symptomatology during and after Short-Term Off-Label Metreleptin Treatment of a\u00a0Patient with Anorexia Nervosa. Obes Facts 16:99\u2013107","journal-title":"Obes Facts"},{"key":"1804_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.biopsych.2004.11.002","volume":"57","author":"CM Grilo","year":"2005","unstructured":"Grilo\u00a0CM, Masheb\u00a0RM, Wilson\u00a0GT (2005) Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a\u00a0randomized double-blind placebo-controlled comparison. Biol Psychiatry 57:301\u2013309","journal-title":"Biol Psychiatry"},{"key":"1804_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2147\/NDT.S80881","volume":"12","author":"AI Guerdjikova","year":"2016","unstructured":"Guerdjikova\u00a0AI, Mori\u00a0N, Casuto\u00a0LS, McElroy\u00a0SL (2016) Novel pharmacologic treatment in acute binge eating disorder\u2014role of lisdexamfetamine. NDT 12:833\u2013841","journal-title":"NDT"},{"key":"1804_CR21","doi-asserted-by":"publisher","first-page":"e2498","DOI":"10.1002\/brb3.2498","volume":"12","author":"R Han","year":"2022","unstructured":"Han\u00a0R, Bian\u00a0Q, Chen\u00a0H (2022) Effectiveness of olanzapine in the treatment of anorexia nervosa: A\u00a0systematic review and meta-analysis. Brain Behav 12:e2498","journal-title":"Brain Behav"},{"key":"1804_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/bmj.323.7308.334","volume":"323","author":"R Harbour","year":"2001","unstructured":"Harbour\u00a0R, Miller\u00a0J (2001) A new system for grading recommendations in evidence based guidelines. BMJ 323:334\u2013336","journal-title":"BMJ"},{"key":"1804_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/15622975.2018.1557346","volume":"20","author":"A Hasan","year":"2019","unstructured":"Hasan\u00a0A, Bandelow\u00a0B, Yatham\u00a0LN, Berk\u00a0M, Falkai\u00a0P, M\u00f6ller\u00a0HJ, Kasper\u00a0S, WFSBP Guideline Task Force Chairs (2019) WFSBP guidelines on how to grade treatment evidence for clinical guideline development. World J Biol Psychiatry 20:2\u201316","journal-title":"World J Biol Psychiatry"},{"key":"1804_CR24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4088\/JCP.v64n1208","volume":"64","author":"DW Hedges","year":"2003","unstructured":"Hedges\u00a0DW, Reimherr\u00a0FW, Hoopes\u00a0SP, Rosenthal\u00a0NR, Kamin\u00a0M, Karim\u00a0R, Capece\u00a0JA (2003) Treatment of bulimia nervosa with topiramate in a\u00a0randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. J\u00a0Clin Psychiatry 64:1449\u20131454","journal-title":"J Clin Psychiatry"},{"key":"1804_CR25","first-page":"3","volume-title":"Gemeinsame","author":"S Herpertz","year":"2018","unstructured":"Herpertz\u00a0S, Fichter\u00a0M, Herpertz-Dahlmann\u00a0B, Hilbert\u00a0A, Tuschen-Caffier\u00a0B, Vocks\u00a0S, Zeeck\u00a0A (2018) Gemeinsame. AWMF, Leitlinie \u201eDiagnostik und Therapie der Essst\u00f6rungen\u201c [Joint German Guideline \u201eDiagnosis and treatment of eating disorders\u201c]. Berlin: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.\u202fV, S\u00a03"},{"key":"1804_CR26","doi-asserted-by":"crossref","unstructured":"Himmerich H, Lewis YD, Conti C, Mutwalli H, Karwautz A, Sj\u00f6gren JM, Uribe Isaza MM, Tyszkiewicz-Nwafor M, Aigner M, McElroy SL, Treasure J, Kasper S; WFSBP Task Force on Eating Disorders (2023) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders. World Journal of Biological Psychiatry 24:1\u201364","DOI":"10.1080\/15622975.2023.2179663"},{"key":"1804_CR27","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4088\/JCP.v64n1109","volume":"64","author":"SP Hoopes","year":"2003","unstructured":"Hoopes\u00a0SP, Reimherr\u00a0FW, Hedges\u00a0DW, Rosenthal\u00a0NR, Kamin\u00a0M, Karim\u00a0R, Capece\u00a0JA, Karvois\u00a0D (2003) Treatment of bulimia nervosa with topiramate in a\u00a0randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J\u00a0Clin Psychiatry 64:1335\u20131341","journal-title":"J Clin Psychiatry"},{"key":"1804_CR28","first-page":"262","volume":"49","author":"RL Horne","year":"1988","unstructured":"Horne\u00a0RL, Ferguson\u00a0JM, Pope\u00a0HG Jr, Hudson\u00a0JI, Lineberry\u00a0CG, Ascher\u00a0J, Cato\u00a0A (1988) Treatment of bulimia with bupropion: a\u00a0multicenter controlled trial. J\u00a0Clin Psychiatry 49:262\u2013266","journal-title":"J Clin Psychiatry"},{"key":"1804_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-12-381272-8.00024-6","volume":"514","author":"M Hotta","year":"2012","unstructured":"Hotta\u00a0M, Ohwada\u00a0R, Akamizu\u00a0T, Shibasaki\u00a0T, Kangawa\u00a0K (2012) Therapeutic potential of ghrelin in restricting-type anorexia nervosa. Meth Enzymol 514:381\u2013398","journal-title":"Meth Enzymol"},{"key":"1804_CR30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1507\/endocrj.K09E-168","volume":"56","author":"M Hotta","year":"2009","unstructured":"Hotta\u00a0M, Ohwada\u00a0R, Akamizu\u00a0T, Shibasaki\u00a0T, Takano\u00a0K, Kangawa\u00a0K (2009) Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: A\u00a0pilot study. Endocr\u00a0J 56:1119\u20131128","journal-title":"Endocr J"},{"key":"1804_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/jamapsychiatry.2017.1889","volume":"74","author":"JI Hudson","year":"2017","unstructured":"Hudson\u00a0JI, McElroy\u00a0SL, Ferreira-Cornwell\u00a0MC, Radewonuk\u00a0J, Gasior\u00a0M (2017) Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A\u00a0Randomized Clinical Trial. Jama Psychiatry 74:903\u2013910","journal-title":"Jama Psychiatry"},{"key":"1804_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/cap.2010.0139","volume":"21","author":"V Kafantaris","year":"2011","unstructured":"Kafantaris\u00a0V, Leigh\u00a0E, Hertz\u00a0S, Berest\u00a0A, Schebendach\u00a0J, Sterling\u00a0WM, Saito\u00a0E, Sunday\u00a0S, Higdon\u00a0C, Golden\u00a0NH, Malhotra\u00a0AK (2011) A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. J\u00a0Child Adolesc Psychopharmacol 21:207\u2013212","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1804_CR33","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.3390\/nu13114158","volume":"13","author":"JL Keeler","year":"2021","unstructured":"Keeler\u00a0JL, Treasure\u00a0J, Juruena\u00a0MF, Kan\u00a0C, Himmerich\u00a0H (2021) Ketamine as a\u00a0Treatment for Anorexia Nervosa: A\u00a0Narrative Review. Nutrients 13:4158","journal-title":"Nutrients"},{"key":"1804_CR34","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/eat.23480","volume":"54","author":"AR Keshen","year":"2021","unstructured":"Keshen\u00a0AR, Dixon\u00a0L, Ali\u00a0SI, Helson\u00a0T, Nunes\u00a0A, Milliken\u00a0H, Gamberg\u00a0S, Sadek\u00a0J, Kaplan\u00a0A, McElroy\u00a0SL (2021) A feasibility study evaluating lisdexamfetamine dimesylate for the treatment of adults with bulimia nervosa. Int J Eat Disord 54:872\u2013878","journal-title":"Int J Eat Disord"},{"key":"1804_CR35","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.4088\/JCP.12r07691","volume":"73","author":"T Kishi","year":"2012","unstructured":"Kishi\u00a0T, Kafantaris\u00a0V, Sunday\u00a0S, Sheridan\u00a0EM, Correll\u00a0CU (2012) Are antipsychotics effective for the treatment of anorexia nervosa? Results from a\u00a0systematic review and meta-analysis. J\u00a0Clin Psychiatry 73:e757\u2013766","journal-title":"J Clin Psychiatry"},{"key":"1804_CR36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/eat.22059","volume":"46","author":"J Lebow","year":"2013","unstructured":"Lebow\u00a0J, Sim\u00a0LA, Erwin\u00a0PJ, Murad\u00a0MH (2013) The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a\u00a0systematic review and meta-analysis. Int J Eat Disord 46:332\u2013339","journal-title":"Int J Eat Disord"},{"key":"1804_CR37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1176\/ajp.147.7.876","volume":"147","author":"MD Marcus","year":"1990","unstructured":"Marcus\u00a0MD, Wing\u00a0RR, Ewing\u00a0L, Kerm\u00a0E, McDermott\u00a0M, Gooding\u00a0W (1990) A double-blind, placebo-controlled trial of fluoxetine plus behaviour modification in the treatment of obese binge-eaters and non-binge-eaters. Am J Psychol 147:876\u2013881","journal-title":"Am J Psychol"},{"key":"1804_CR38","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.08.008","volume":"61","author":"SL McElroy","year":"2007","unstructured":"McElroy\u00a0SL, Hudson\u00a0JI, Capece\u00a0JA, Beyers\u00a0K, Fisher\u00a0AC, Rosenthal\u00a0NR (2007) Topiramate Binge Eating Disorder Research Group. Topiramate for the treatment of binge eating disorder associated with obesity: a\u00a0placebo-controlled study. Biol Psychiatry 61:1039\u20131048","journal-title":"Biol Psychiatry"},{"key":"1804_CR39","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/npp.2015.275","volume":"41","author":"SL McElroy","year":"2016","unstructured":"McElroy\u00a0SL, Hudson\u00a0J, Ferreira-Cornwell\u00a0MC, Radewonuk\u00a0J, Whitaker\u00a0T, Gasior\u00a0M (2016) Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase\u00a03 Randomized Controlled Trials. Neuropsychopharmacology 41:1251\u20131260","journal-title":"Neuropsychopharmacology"},{"key":"1804_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jamapsychiatry.2014.2162","volume":"72","author":"SL McElroy","year":"2015","unstructured":"McElroy\u00a0SL, Hudson\u00a0JI, Mitchell\u00a0JE, Wilfley\u00a0D, Ferreira-Cornwell\u00a0MC, Gao\u00a0J, Wang\u00a0J, Whitaker\u00a0T, Jonas\u00a0J, Gasior\u00a0M (2015) Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a\u00a0randomized clinical trial. Jama Psychiatry 72:235\u2013246","journal-title":"Jama Psychiatry"},{"key":"1804_CR41","doi-asserted-by":"crossref","unstructured":"Mills IH, Park GR, Manara AR, Merriman RJ (1998) Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions. QJM An International Journal of Medicine 91:493\u2013503","DOI":"10.1093\/qjmed\/91.7.493"},{"key":"1804_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41398-020-00977-1","volume":"10","author":"G Milos","year":"2020","unstructured":"Milos\u00a0G, Antel\u00a0J, Kaufmann\u00a0LK, Barth\u00a0N, Koller\u00a0A, Tan\u00a0S, Wiesing\u00a0U, Hinney\u00a0A, Libuda\u00a0L, Wabitsch\u00a0M, von K\u00e4nel\u00a0R, Hebebrand\u00a0J (2020) Short-term metreleptin treatment of patients with anorexia nervosa: rapid on-set of beneficial cognitive, emotional, and behavioral effects. Transl Psychiatry 10:303","journal-title":"Transl Psychiatry"},{"key":"1804_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/eat.20202","volume":"38","author":"C Nickel","year":"2005","unstructured":"Nickel\u00a0C, Tritt\u00a0K, Muehlbacher\u00a0M, Pedrosa\u00a0GF, Mitterlehner\u00a0FO, Kaplan\u00a0P, Lahmann\u00a0C, Leiberich\u00a0PK, Krawczyk\u00a0J, Kettler\u00a0C, Rother\u00a0WK, Loew\u00a0TH, Nickel\u00a0MK (2005) Topiramate treatment in bulimia nervosa patients: a\u00a0randomized, double-blind, placebo-controlled trial. Int J Eat Disord 38:295\u2013300","journal-title":"Int J Eat Disord"},{"key":"1804_CR44","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1038\/s41591-023-02455-9","volume":"29","author":"SK Peck","year":"2023","unstructured":"Peck\u00a0SK, Shao\u00a0S, Gruen\u00a0T, Yang\u00a0K, Babakanian\u00a0A, Trim\u00a0J, Finn\u00a0DM, Kaye\u00a0WH (2023) Psilocybin therapy for females with anorexia nervosa: a\u00a0phase\u00a01, open-label feasibility study. Nat Med 29:1947\u20131953","journal-title":"Nat Med"},{"key":"1804_CR45","doi-asserted-by":"crossref","unstructured":"Perrain R, Mekaoui L, Gorwood P (2024) Esketamine in the Treatment of Depression with Co-Morbid Anorexia Nervosa. International Journal of Clinical Studies and Medical Case Reports 37:004","DOI":"10.46998\/IJCMCR.2024.37.000904"},{"key":"1804_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.orcp.2015.03.005","volume":"9","author":"SA Robert","year":"2015","unstructured":"Robert\u00a0SA, Rohana\u00a0AG, Shah\u00a0SA, Chinna\u00a0K, Mohamud\u00a0WWN, Kamaruddin\u00a0NA (2015) Improvement in binge eating in non-diabetic obese individuals after 3\u00a0months of treatment with liraglutide\u2014A pilot study. Obes Res Clin Pract 9:301\u2013304","journal-title":"Obes Res Clin Pract"},{"key":"1804_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1176\/appi.ajp.159.1.96","volume":"159","author":"SJ Romano","year":"2002","unstructured":"Romano\u00a0SJ, Halmi\u00a0KA, Sarkar\u00a0NP, Koke\u00a0SC, Lee\u00a0JS (2002) A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry 159:96\u2013102","journal-title":"Am J Psychiatry"},{"key":"1804_CR48","doi-asserted-by":"publisher","first-page":"e03869","DOI":"10.1002\/ccr3.3869","volume":"9","author":"T Schwartz","year":"2021","unstructured":"Schwartz\u00a0T, Trunko\u00a0ME, Feifel\u00a0D, Lopez\u00a0E, Peterson\u00a0D, Frank\u00a0GKW, Kaye\u00a0W (2021) A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment-resistant depression. Clin Case Rep 9:e3869","journal-title":"Clin Case Rep"},{"key":"1804_CR49","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fpsyt.2020.00763","volume":"11","author":"B Scolnick","year":"2020","unstructured":"Scolnick\u00a0B, Zupec-Kania\u00a0B, Calabrese\u00a0L, Aoki\u00a0C, Hildebrandt\u00a0T (2020) Remission from Chronic Anorexia Nervosa With Ketogenic Diet and Ketamine: Case Report. Front Psychiatry 11:763","journal-title":"Front Psychiatry"},{"key":"1804_CR50","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","volume":"71","author":"A Serretti","year":"2010","unstructured":"Serretti\u00a0A, Mandelli\u00a0L (2010) Antidepressants and body weight: a\u00a0comprehensive review and meta-analysis. Cournal Clin Psychiatry 71:1259\u20131272","journal-title":"Cournal Clin Psychiatry"},{"key":"1804_CR51","doi-asserted-by":"crossref","unstructured":"Solmi M, Monaco F, H\u00f8jlund M, Monteleone AM, Trott M, Firth J, Carfagno M, Eaton M, De Toffol M, Vergine M, Meneguzzo P, Collantoni E, Gallicchio D, Stubbs B, Girardi A, Busetto P, Favaro A, Carvalho AF, Steinhausen HC, Correll CU (2024) Outcomes in people with eating disorders: a\u00a0transdiagnostic and disorder-specific systematic review, meta-analysis and multivariable meta-regression analysis. World Psychiatry 23:124\u2013138","DOI":"10.1002\/wps.21182"},{"key":"1804_CR52","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1176\/appi.ajp.157.8.1332","volume":"157","author":"BT Walsh","year":"2000","unstructured":"Walsh\u00a0BT, Agras\u00a0WS, Devlin\u00a0MJ, Fairburn\u00a0CG, Wilson\u00a0GT, Kahn\u00a0C, Chally\u00a0MK (2000) Fluoxetine for bulimia nervosa following poor response to psychotherapy. Am J Psychiatry 157:1332\u20131334","journal-title":"Am J Psychiatry"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-025-01804-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:03:17Z","timestamp":1746608597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-025-01804-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1804"],"URL":"https:\/\/doi.org\/10.1007\/s00115-025-01804-y","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"13 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Bauman und U.\u00a0Voderholzer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}